AHSZX
Price
$20.26
Change
-$0.32 (-1.55%)
Updated
Feb 21 closing price
Net Assets
79.85M
JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

AHSZX vs JNGLX

Header iconAHSZX vs JNGLX Comparison
Open Charts AHSZX vs JNGLXBanner chart's image
Alger Health Sciences Z
Price$20.26
Change-$0.32 (-1.55%)
VolumeN/A
Net Assets79.85M
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
AHSZX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AHSZX vs. JNGLX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AHSZX is a StrongBuy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5B vs. AHSZX (79.9M). JNGLX pays higher dividends than AHSZX: JNGLX (0.12) vs AHSZX (0.00). AHSZX was incepted earlier than JNGLX: AHSZX (10 years) vs JNGLX (26 years). AHSZX is a more actively managed with annual turnover of: 305.60 vs. JNGLX (34.00). JNGLX has a lower initial minimum investment than AHSZX: JNGLX (2500) vs AHSZX (500000). JNGLX annual gain was more profitable for investors over the last year : -3.67 vs. AHSZX (-8.86). JNGLX return over 5 years is better than : 17.54 vs. AHSZX (-29.94).
AHSZXJNGLXAHSZX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years26 years-
Gain YTD-4.7485.421-88%
Front LoadN/AN/A-
Min. Initial Investment500000250020,000%
Min. Initial Investment IRAN/AN/A-
Net Assets79.9M5B2%
Annual Yield % from dividends0.000.12-
Returns for 1 year-8.86-3.67241%
Returns for 3 years-7.7815.97-49%
Returns for 5 years-29.9417.54-171%
Returns for 10 yearsN/A29.25-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P